A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers

Clinical trial NCT00522808 · TERMINATED

Trial details

NCT number: NCT00522808
Sponsor: Arrow Therapeutics
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2007-08-01
Primary completion: 2008-03-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.